Mechanisms in endocrinology: hypogonadism and metabolic health in men—novel insights into pathophysiology
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Hypogonadism in men is associated with an adverse metabolic phenotype and increased mortality. Reciprocally, obesity and insulin resistance can suppress the hypothalamic–pituitary–gonadal axis in the absence of structural organic disease, further perpetuating a cycle of metabolic dysfunction and low testosterone. The mechanisms underpinning this bidirectional association are complex as hypogonadism is a heterogenous syndrome, and obesity is associated with metabolic perturbations in glucose and lipid metabolism even in the presence of normal testicular function. However, distinct molecular defects specific to testosterone deficiency have been identified in pathways relating to glucose and lipid metabolism in target metabolic depots such as adipose tissue and skeletal muscle. This review discusses the etiology and prevalence of metabolic disease in male hypogonadism, with a specific focus on both disease mechanisms and novel potential approaches to enhance our understanding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Male hypogonadism, resulting in low serum testosterone concentrations, has been associated with an adverse metabolic phenotype and even increased mortality (174-176).”
From Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity (2025) · cites this paper as [176]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B., & Flier, J. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1311 · Cited by 1,660
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Blüher, M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa004 · Cited by 1,090
Vigen, R. (2013) · JAMA · doi:10.1001/jama.2013.280386 · Cited by 1,003
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967
Androgens Decrease Plasma Adiponectin, an Insulin-Sensitizing Adipocyte-Derived Protein
Nishizawa, H., Shimomura, I., Kishida, K., Maeda, N., Kuriyama, H., Nagaretani, H., Matsuda, M., Kondo, H., Furuyama, N., Kihara, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2734 · Cited by 837
Low Serum Testosterone and Mortality in Older Men
Laughlin, G. A., Barrett-Connor, E., & Bergstrom, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1792 · Cited by 798
Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791
Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men
Finkelstein, J. S., Lee, H., Burnett-Bowie, S.-A. M., Pallais, J. C., Yu, E. W., Borges, L. F., Jones, B. F., Barry, C. V., Wulczyn, K. E., Thomas, B. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1206168 · Cited by 782
Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N. (2007) · Circulation · doi:10.1161/circulationaha.107.719005 · Cited by 743
Research works printed but not linked: 109
- Calderón, 2016, Prevalence of male secondary hypogonadism in moderate to severe obesity and its relationship with insulin resistance and excess body weight, Andrology, 4, 62, 10.1111/andr.12135 · DOI · Paper page
- Hamilton, 2011, Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy, Clin Endocrinol (Oxf), 74, 377, 10.1111/j.1365-2265.2010.03942.x · DOI · Paper page
- Maseroli, 2021, Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men, J Endocrinol Invest, 44, 819, 10.1007/s40618-020-01381-8 · DOI
- Kelly, 2016, Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse, Endocrine, 54, 504, 10.1007/s12020-016-1019-1 · DOI · Paper page
- de Siqueira Guedes, 2022, Plasma metabolome study reveals metabolic changes induced by pharmacological castration and testosterone supplementation in healthy young men, Sci Rep, 12, 15931, 10.1038/s41598-022-19494-w · DOI
- Gevi, 2018, Metabolic patterns in insulin-resistant male hypogonadism, Cell Death Dis, 9, 671, 10.1038/s41419-018-0587-9 · DOI
- Fanelli, 2018, Metabolic patterns in insulin-sensitive male hypogonadism, Cell Death Dis, 9, 653, 10.1038/s41419-018-0588-8 · DOI
- Ghanim, 2020, Testosterone increases the expression and phosphorylation of AMP kinase α in men with hypogonadism and type 2 diabetes, J Clin Endocrinol Metab, 105, 1169, 10.1210/clinem/dgz288 · DOI
- George, 2013, Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism, Clin Endocrinol (Oxf), 79, 100, 10.1111/cen.12103 · DOI · Paper page
- Castellano, 2006, Expression of hypothalamic KiSS-1 system and rescue of defective gonadotropic responses by kisspeptin in streptozotocin-induced diabetic male rats, Diabetes, 55, 2602, 10.2337/db05-1584 · DOI · Paper page
- Villa, 2024, Obesity alters POMC and kisspeptin neuron cross talk leading to reduced luteinizing hormone in male mice, J Neurosci, 44, e0222242024, 10.1523/JNEUROSCI.0222-24.2024 · DOI
- Zhai, 2018, Downregulation of leptin receptor and kisspeptin/GPR54 in the murine hypothalamus contributes to male hypogonadism caused by high-fat diet-induced obesity, Endocrine, 62, 195, 10.1007/s12020-018-1646-9 · DOI
- Wake, 2007, Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity, Clin Endocrinol (Oxf), 66, 440, 10.1111/j.1365-2265.2007.02755.x · DOI · Paper page
- Lanfranco, 2004, Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy, Clin Endocrinol (Oxf), 60, 500, 10.1111/j.1365-2265.2004.02007.x · DOI · Paper page
- Kapoor, 2007, The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes, Eur J Endocrinol, 156, 595, 10.1530/EJE-06-0737 · DOI · Paper page
- Gannagé-Yared, 2006, Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men, Eur J Endocrinol, 155, 167, 10.1530/eje.1.02175 · DOI · Paper page
- Isidori, 1999, Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels, J Clin Endocrinol Metab, 84, 3673, 10.1210/jcem.84.10.6082 · DOI · Paper page
- Pizzocaro, 2020, Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis, J Endocrinol Invest, 43, 1675, 10.1007/s40618-020-01299-1 · DOI
- Sonmez, 2011, Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism, Eur J Endocrinol, 164, 759, 10.1530/EJE-10-0951 · DOI
- Zolla, 2022, Plasma metabolomics profile of “insulin sensitive” male hypogonadism after testosterone replacement therapy, Int J Mol Sci, 23, 1916, 10.3390/ijms23031916 · DOI
- Zolla, 2022, Plasma metabonomics in insulin-resistant hypogonadic patients induced by testosterone treatment, Int J Mol Sci, 23, 7754, 10.3390/ijms23147754 · DOI
- Salas-Huetos, 2021, Male adiposity, sperm parameters and reproductive hormones: an updated systematic review and collaborative meta-analysis, Obes Rev, 22, e13082, 10.1111/obr.13082 · DOI · Paper page
- Tsai, 2000, Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men, Int J Obes Relat Metab Disord, 24, 485, 10.1038/sj.ijo.0801183 · DOI · Paper page
- Ghanim, 2018, Diminished androgen and estrogen receptors and aromatase levels in hypogonadal diabetic men: reversal with testosterone, Eur J Endocrinol, 178, 277, 10.1530/EJE-17-0673 · DOI · Paper page
- Bekaert, 2015, Determinants of testosterone levels in human male obesity, Endocrine, 50, 202, 10.1007/s12020-015-0563-4 · DOI · Paper page
- Jones, 2023, Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial, Eur J Endocrinol, 189, 297, 10.1093/ejendo/lvad099 · DOI
- Dhindsa, 2016, Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes, Diabetes Care, 39, 82, 10.2337/dc15-1518 · DOI · Paper page
- Kalinchenko, 2010, Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study, Clin Endocrinol (Oxf), 73, 602, 10.1111/j.1365-2265.2010.03845.x · DOI · Paper page
- Caprio, 1999, Expression of functional leptin receptors in rodent Leydig cells, Endocrinology, 140, 4939, 10.1210/endo.140.11.7088 · DOI · Paper page
- Ishikawa, 2007, Expression of leptin and leptin receptor in the testis of fertile and infertile patients, Andrologia, 39, 22, 10.1111/j.1439-0272.2006.00754.x · DOI
- Tena-Sempere, 2002, Leptin in male reproduction: the testis paradigm, Mol Cell Endocrinol, 188, 9, 10.1016/S0303-7207(02)00008-4 · DOI · Paper page
- McInnes, 2012, Deletion of the androgen receptor in adipose tissue in male mice elevates retinol binding protein 4 and reveals independent effects on visceral fat mass and on glucose homeostasis, Diabetes, 61, 1072, 10.2337/db11-1136 · DOI · Paper page
- Page, 2005, Testosterone administration suppresses adiponectin levels in men, J Androl, 26, 85, 10.1002/j.1939-4640.2005.tb02876.x · DOI · Paper page
- Landry, 2015, Adiponectin influences progesterone production from MA-10 Leydig cells in a dose-dependent manner, Endocrine, 48, 957, 10.1007/s12020-014-0456-y · DOI
- Bojesen, 2006, The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism, Diabetes Care, 29, 1591, 10.2337/dc06-0145 · DOI · Paper page
- Aversa, 2010, Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study, J Sex Med, 7, 3495, 10.1111/j.1743-6109.2010.01931.x · DOI · Paper page
- Alwani, 2021, Cardiovascular disease, hypogonadism and erectile dysfunction: early detection, prevention and the positive effects of long-term testosterone treatment: prospective observational, real-life data, Vasc Health Risk Manag, 17, 497, 10.2147/VHRM.S309714 · DOI
- Sarchielli, 2017, Tumor necrosis factor-α impairs kisspeptin signaling in human gonadotropin-releasing hormone primary neurons, J Clin Endocrinol Metab, 102, 46, 10.1210/jc.2016-2115 · DOI · Paper page
- Ebrahimi, 2018, IL-1 antagonism in men with metabolic syndrome and low testosterone: a randomized clinical trial, J Clin Endocrinol Metab, 103, 3466, 10.1210/jc.2018-00739 · DOI · Paper page
- Hammoud, 2009, Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men, J Clin Endocrinol Metab, 94, 1329, 10.1210/jc.2008-1598 · DOI · Paper page
- Ken-Dror, 2024, Meta-analysis and construction of simple-to-use nomograms for approximating testosterone levels gained from weight loss in obese men, Andrology, 12, 297, 10.1111/andr.13484 · DOI
- Calderón, 2014, Effects of bariatric surgery on male obesity-associated secondary hypogonadism: comparison of laparoscopic gastric bypass with restrictive procedures, Obes Surg, 24, 1686, 10.1007/s11695-014-1233-y · DOI
- Walsh, 2019, Testosterone replacement in young male cancer survivors: a 6-month double-blind randomised placebo-controlled trial, PLoS Med, 16, e1002960, 10.1371/journal.pmed.1002960 · DOI
- Corona, 2016, Testosterone supplementation and body composition: results from a meta-analysis of observational studies, J Endocrinol Invest, 39, 967, 10.1007/s40618-016-0480-2 · DOI · Paper page
- Kumar, 2022, Effects of testosterone therapy in adult males with hypogonadism and T2DM: a meta-analysis and systematic review, Diabetes Metab Syndr, 16, 102588, 10.1016/j.dsx.2022.102588 · DOI
- Mangolim, 2022, Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis, Eur J Endocrinol, 186, 123, 10.1530/EJE-21-0473 · DOI
- Wittert, 2023, Testosterone and type 2 diabetes prevention: translational lessons from the T4DM study, J Endocrinol, 258, e220223, 10.1530/JOE-22-0223 · DOI
- Thirumalai, 2017, Dose-response effects of sex hormone concentrations on body composition and adipokines in medically castrated healthy men administered graded doses of testosterone gel, Clin Endocrinol (Oxf), 87, 59, 10.1111/cen.13342 · DOI
- Cheung, 2016, Relationships between insulin resistance and frailty with body composition and testosterone in men undergoing androgen deprivation therapy for prostate cancer, Eur J Endocrinol, 175, 229, 10.1530/EJE-16-0200 · DOI · Paper page
- Mårin, 1992, The effects of testosterone treatment on body composition and metabolism in middle-aged obese men, Int J Obes Relat Metab Disord, 16, 991
- Rebuffé-Scrive, 1991, Effect of testosterone on abdominal adipose tissue in men, Int J Obes, 15, 791
- Fujioka, 2012, Dehydroepiandrosterone reduces preadipocyte proliferation via androgen receptor, Am J Physiol Endocrinol Metab, 302, E694, 10.1152/ajpendo.00112.2011 · DOI · Paper page
- Blouin, 2010, Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women, Clin Endocrinol (Oxf), 72, 176, 10.1111/j.1365-2265.2009.03645.x · DOI · Paper page
- Varlamov, 2012, Androgen effects on adipose tissue architecture and function in nonhuman primates, Endocrinology, 153, 3100, 10.1210/en.2011-2111 · DOI · Paper page
- Ngo, 2023, Mitochondrial morphology controls fatty acid utilization by changing CPT1 sensitivity to malonyl-CoA, EMBO J, 42, e111901, 10.15252/embj.2022111901 · DOI · Paper page
- Xu, 1990, The effects of androgens on the regulation of lipolysis in adipose precursor cells, Endocrinology, 126, 1229, 10.1210/endo-126-2-1229 · DOI · Paper page
- Xu, 1991, Testosterone increases lipolysis and the number of beta-adrenoceptors in male rat adipocytes, Endocrinology, 128, 379, 10.1210/endo-128-1-379 · DOI · Paper page
- Hernández-Morante, 2008, Role of DHEA-S on body fat distribution: gender- and depot-specific stimulation of adipose tissue lipolysis, Steroids, 73, 209, 10.1016/j.steroids.2007.10.005 · DOI
- Karbowska, 2012, Fat-reducing effects of dehydroepiandrosterone involve upregulation of ATGL and HSL expression, and stimulation of lipolysis in adipose tissue, Steroids, 77, 1359, 10.1016/j.steroids.2012.08.002 · DOI
- Kim, 2019, Inhibition of androgen receptor can decrease fat metabolism by decreasing carnitine palmitoyltransferase I levels in skeletal muscles of trained mice, Nutr Metab (Lond), 16, 82, 10.1186/s12986-019-0406-z · DOI
- Rubinow, 2012, Acute testosterone deprivation reduces insulin sensitivity in men, Clin Endocrinol (Oxf), 76, 281, 10.1111/j.1365-2265.2011.04189.x · DOI · Paper page
- Ottarsdottir, 2018, The association between serum testosterone and insulin resistance: a longitudinal study, Endocr Connect, 7, 1491, 10.1530/EC-18-0480 · DOI
- Fan, 2022, Changes in levels of testosterone, insulin sensitivity and metabolic profiles during GnRH therapy: reciprocity between insulin sensitivity and pituitary responsiveness to GnRH in teenage and young male patients with congenital hypogonadotropic hypogonadism, Clin Endocrinol (Oxf), 97, 783, 10.1111/cen.14829 · DOI
- Traish, 2017, Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism: a real-life observational registry study setting comparing treated and untreated (control) groups, J Cardiovasc Pharmacol Ther, 22, 414, 10.1177/1074248417691136 · DOI · Paper page
- Mohler, 2018, The effect of testosterone on cardiovascular biomarkers in the testosterone trials, J Clin Endocrinol Metab, 103, 681, 10.1210/jc.2017-02243 · DOI · Paper page
- Bhasin, 2024, Effect of testosterone on progression from prediabetes to diabetes in men with hypogonadism: a substudy of the TRAVERSE randomized clinical trial, JAMA Intern Med, 184, 353, 10.1001/jamainternmed.2023.7862 · DOI
- Robledo, 2023, Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the testosterone for prevention of type 2 diabetes mellitus trial, Eur J Endocrinol, 189, 50, 10.1093/ejendo/lvad074 · DOI
- Pitteloud, 2005, Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men, J Clin Endocrinol Metab, 90, 2636, 10.1210/jc.2004-2190 · DOI · Paper page
- Ermetici, 2009, Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function, Eur J Endocrinol, 161, 853, 10.1530/EJE-09-0203 · DOI
- Ahn, 2013, Insulin directly regulates steroidogenesis via induction of the orphan nuclear receptor DAX-1 in testicular Leydig cells, J Biol Chem, 288, 15937, 10.1074/jbc.M113.451773 · DOI · Paper page
- Leisegang, 2018, The in vitro modulation of steroidogenesis by inflammatory cytokines and insulin in TM3 Leydig cells, Reprod Biol Endocrinol, 16, 26, 10.1186/s12958-018-0341-2 · DOI
- Navarro, 2016, Extranuclear actions of the androgen receptor enhance glucose-stimulated insulin secretion in the male, Cell Metab, 23, 837, 10.1016/j.cmet.2016.03.015 · DOI · Paper page
- Xu, 2023, Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cells, Cell Rep, 42, 112529, 10.1016/j.celrep.2023.112529 · DOI
- Xu, 2020, Intracrine testosterone activation in human pancreatic β-cells stimulates insulin secretion, Diabetes, 69, 2392, 10.2337/db20-0228 · DOI
- Mitsuhashi, 2016, Testosterone stimulates glucose uptake and GLUT4 translocation through LKB1/AMPK signaling in 3T3-L1 adipocytes, Endocrine, 51, 174, 10.1007/s12020-015-0666-y · DOI
- Schiffer, 2017, MECHANISMS IN ENDOCRINOLOGY: the sexually dimorphic role of androgens in human metabolic disease, Eur J Endocrinol, 177, R125, 10.1530/EJE-17-0124 · DOI · Paper page
- Montano, 2007, Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss, J Clin Endocrinol Metab, 92, 2793, 10.1210/jc.2006-2722 · DOI
- Petersson, 2014, Effect of testosterone on markers of mitochondrial oxidative phosphorylation and lipid metabolism in muscle of aging men with subnormal bioavailable testosterone, Eur J Endocrinol, 171, 77, 10.1530/EJE-14-0006 · DOI · Paper page
- Holmäng, 1992, The effects of testosterone on insulin sensitivity in male rats, Acta Physiol Scand, 146, 505, 10.1111/j.1748-1716.1992.tb09452.x · DOI · Paper page
- Haren, 2011, Testosterone modulates gene expression pathways regulating nutrient accumulation, glucose metabolism and protein turnover in mouse skeletal muscle, Int J Androl, 34, 55, 10.1111/j.1365-2605.2010.01061.x · DOI · Paper page
- Sato, 2008, Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle, Am J Physiol Endocrinol Metab, 294, E961, 10.1152/ajpendo.00678.2007 · DOI · Paper page
- Davis, 2022, Population-based assessment of cardiometabolic-related diagnoses in youth with Klinefelter syndrome: a PEDSnet study, J Clin Endocrinol Metab, 107, e1850, 10.1210/clinem/dgac056 · DOI
- Bosco, 2015, Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis, PLoS One, 10, e0117344, 10.1371/journal.pone.0117344 · DOI · Paper page
- Haring, 2011, Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia, Eur J Cardiovasc Prev Rehabil, 18, 86, 10.1097/HJR.0b013e32833c1a8d · DOI · Paper page
- Vikan, 2009, Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø study, Eur J Endocrinol, 161, 435, 10.1530/EJE-09-0284 · DOI · Paper page
- Zhang, 2014, The relationship between endogenous testosterone and lipid profile in middle-aged and elderly Chinese men, Eur J Endocrinol, 170, 487, 10.1530/EJE-13-0802 · DOI
- Herbst, 2003, Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk, Am J Physiol Endocrinol Metab, 284, E1112, 10.1152/ajpendo.00524.2002 · DOI · Paper page
- Schleich, 2004, Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male, Eur J Endocrinol, 151, 415, 10.1530/eje.0.1510415 · DOI · Paper page
- Singh, 2002, The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men, J Clin Endocrinol Metab, 87, 136, 10.1210/jcem.87.1.8172 · doi:10.1210/jcem.87.1.8172 · Paper page
- Langer, 2002, Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages, Biochem Biophys Res Commun, 296, 1051, 10.1016/S0006-291X(02)02038-7 · DOI
- Rubinow, 2012, Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men, Steroids, 77, 454, 10.1016/j.steroids.2012.01.002 · DOI
- Adorni, 2019, High-density lipoprotein function is reduced in patients affected by genetic or idiopathic hypogonadism, J Clin Endocrinol Metab, 104, 3097, 10.1210/jc.2018-02027 · DOI
- Haring, 2010, Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79, Eur Heart J, 31, 1494, 10.1093/eurheartj/ehq009 · DOI · Paper page
- Ohlsson, 2023, Serum DHEA and testosterone levels associate inversely with coronary artery calcification in elderly men, J Clin Endocrinol Metab, 108, 3272, 10.1210/clinem/dgad351 · DOI
- Sharma, 2015, Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men, Eur Heart J, 36, 2706, 10.1093/eurheartj/ehv346 · DOI · Paper page
- Jasuja, 2019, Health outcomes among long-term opioid users with testosterone prescription in the veterans health administration, JAMA Netw Open, 2, e1917141, 10.1001/jamanetworkopen.2019.17141 · DOI
- Budoff, 2017, Testosterone treatment and coronary artery plaque volume in older men with low testosterone, JAMA, 317, 708, 10.1001/jama.2016.21043 · DOI · Paper page
- Ajayi, 2005, Castration reduces platelet thromboxane A2 receptor density and aggregability, QJM, 98, 349, 10.1093/qjmed/hci054 · DOI · Paper page
- Lincoff, 2023, Cardiovascular safety of testosterone-replacement therapy, N Engl J Med, 389, 107, 10.1056/NEJMoa2215025 · DOI · Paper page
- Tomlinson, 2001, Association between premature mortality and hypopituitarism. West midlands prospective hypopituitary study group, Lancet, 357, 425, 10.1016/s0140-6736(00)04006-x · DOI · Paper page
- Bojesen, 2004, Increased mortality in Klinefelter syndrome, J Clin Endocrinol Metab, 89, 3830, 10.1210/jc.2004-0777 · DOI · Paper page
- O'Reilly, 2016, ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres, Clin Endocrinol (Oxf), 85, 748, 10.1111/cen.13141 · DOI · Paper page
- Araujo, 2007, Sex steroids and all-cause and cause-specific mortality in men, Arch Intern Med, 167, 1252, 10.1001/archinte.167.12.1252 · DOI · Paper page
- Holmboe, 2018, Individual testosterone decline and future mortality risk in men, Eur J Endocrinol, 178, 121–, 10.1530/EJE-17-0280 · DOI
- Muraleedharan, 2013, Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes, Eur J Endocrinol, 169, 725, 10.1530/EJE-13-0321 · DOI · Paper page
- Supplitt, 2021, Current achievements and applications of transcriptomics in personalized cancer medicine, Int J Mol Sci, 22, 1422, 10.3390/ijms22031422 · DOI
- Cai, 2014, Castration-induced changes in microRNA expression profiles in subcutaneous adipose tissue of male pigs, J Appl Genet, 55, 259, 10.1007/s13353-014-0194-0 · DOI
- Cai, 2015, Transcriptomic analysis of hepatic responses to testosterone deficiency in miniature pigs fed a high-cholesterol diet, BMC Genomics, 16, 59, 10.1186/s12864-015-1283-0 · DOI
- Nash, 2019, From mass to metabolite in human untargeted metabolomics: recent advances in annotation of metabolites applying liquid chromatography-mass spectrometry data, Trends Analyt Chem, 120, 115324, 10.1016/j.trac.2018.11.022 · DOI
Cited by
van Santen, H. M., & Müller, H. L. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf025 · Cited by 21
Metadata
- Authors
- Miller, C., Madden-Doyle, L., Jayasena, C., McIlroy, M., Sherlock, M., & O’Reilly, M. W.
- Affiliations
- Academic Department of Endocrinology, Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences , Dublin ,
- Department of Metabolism, Digestion and Reproduction, Imperial College , London ,
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-11-22
- Volume
- 191
- Issue
- 6
- Pages
- R1-R17
- ISSN
- 0804-4643
- 1479-683X
- Cited by
- 28
- References
- 54
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanisms in endocrinology: hypogonadism and metabolic health in men—novel insights into pathophysiology. https://app.cochat.ai/papers/10.1093/ejendo/lvae128
- The paper
- Miller, C., Madden-Doyle, L., Jayasena, C., McIlroy, M., Sherlock, M., & O’Reilly, M. W. (2024). Mechanisms in endocrinology: hypogonadism and metabolic health in men—novel insights into pathophysiology. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae128
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.